Showing posts with label 2 types of bacteria. Show all posts
Showing posts with label 2 types of bacteria. Show all posts

Wednesday, February 22, 2012

On wednesday, the fda will ask the panel ...

(CBS / AP) Prevention of pneumococcal disease is the focus, with federal health researchers said popular Prevnar vaccine, at least as effective as rival vaccine for protection against adults sometimes deadly infections. Prevenar 13 is designed to block infection by 13 strains of the disease, which causes ear infections, meningitis and pneumonia. Prevnar Vaccination is strongly recommended for all infants and young children because of their vulnerability to infection. But the disease also affects 36,000 older people per year, killing 5,000, CDC says. Manufacturer Prevnar, in drug giant Pfizer, has asked FDA to extend approval of the vaccine for adults 50 years and older. In a review published online Monday, scientists, reports Prevnar caused the reaction of the immune system can be compared to Pneumovax Merck, the only pneumococcal vaccine currently approved for adults. In six trials involving more than 6,000 adults, Prevnar vaccine generated at least as many antibodies against pneumococcal infection, as Pneumovax. Side effects to the vaccine were compared, including swelling and redness at the injection site and fever, chills and fatigue. On Wednesday, the FDA will ask a group of independent experts or Prevnar is safe and effective for adults. Recommendations of the group is not mandatory, but the agency often to his advice. CDC currently recommends Pneumovax for adults 65 and older. Only two thirds of the elderly are entitled to receive an injection. But the vaccine has been shown to protect against pneumococcal pneumonia, one of the most dangerous infections associated with the disease. Because of its potential to protect against pneumonia, FDA agreed to Prevnar accelerated six-month review, unlike the usual nine months. Pfizer holds 85 000 inpatient studies in the Netherlands to assess the strength Prevnar against pneumonia in adults. The company shall submit the results of the FDA after the study concludes that, as expected in the next two years. Pneumovax approved only for children over two years and adults over 65 years. Prevnar is designed for children aged six weeks. Pneumovax sells for about $ 50 frame, on average, while Prevenar 13 costs $ 114 on average. Adults need one or two Pneumovax shots and then booster after 65 years. Pfizer did not specify how many Prevnar boosters will be needed after the first dose. Because the vaccine protects against the company Merck strain not covered by strattera no prescritpion Prevnar, it is likely both get older. CDC has. .

After 24 hours, this inoculated agar mcconkie

Klebsiella pneumonia

is a Gram-negative, stationary, optionally anaerobic >> << include >> << Enterobacteriaceae family of proteobakteriya class << type >> proteobakteriya. K. pneumonia


consists of straight rods 1 to 2 lm (micrometers)


in length with a thick, surrounding capsule


(


). In cultivation, this species produces


characteristic smell of yeast and bacterial colonies


have sticky / slimy kind (


). K. pneumonia usually



is in the human digestive tract, as part of the natural microflora >> << and is often caused by


hospital acquired or nosocomial infections


associated with urinary and pulmonary systems


especially as he is able to adapt to the existence


in oxygenated or deoxygenated environment >>. << Immunocomprimised people


(people with AIDS or cancer)



infected with K. pneumonia pneumonia


,


but blood infection (


septecemia ), wound or surgical site infections, and



meningitis are also possible. Figure 1. This scanning electron microscope shows some


ultrastructural morphological features of pneumonia bacterium Klebsiella. Figure 2. After 24 hours, this inoculated agar McConkie


culture plate cultivated colonial growth


Gram-negative, small bacilliform and optionally anaerobic



<< bacterium Klebsiella >> pneumonia. This agent >> << has many virulence factors that allow >> << go unnoticed by owners immune system and cause infection


in different directions. First


uses this type of iron-siderofora receptors activate host


th


enterobactin mediated iron insulating system enabling


for bacterial growth. Their thick polysaccharide capsule >>


prevent the ingestion of phagocytes and somatic antigens on


revealed owners antibodies. In addition, serum complement activation



harder with a thick capsule lipopolysaccharides he has


(Greenwood et al., 2002). In fact


,



K. pneumonia avoid damaging complement proteins


extreme length of the molecule >> << stock capsules, which can significantly


lytic C5b-9 (application) form a complex too far


on the membrane. This prevents << opsonizatsiyi >> and


membrane attack complex (MAC) insertion, resulting in lysis of bacteria


(


). Figure 3. Scheme


represent capsules from solution C3b


addition of protein to initiate complement cascade


. There are many metabolic features >>


. << K. pneumonia, which make it unique



For a start, this bacterium produces an enzyme called


carbapenemase,


making it resistant to the drug karbapenemov. This type


produce bacteriocins that


protein toxins produced by bacteria in the


suppress the growth of similar or closely related


bacterial strains (Greenwood


al.


2002). Since


,


K. pneumonia usually found in microflora


host production


bactericins can actually be harmful, because


can get rid of significant or good bacteria


found in the intestines. K. pneumonia


You can also use sodium citrate and may dekarboksylyrovat



some amino acids to form amines (Forbes et al., 2002). Two other features



metabolic capabilities include pathogenic glycoside hydrolysis



esculine and inability to split tryptophan into indole form


(Greenwood et al., 2002). Morphology, Morphology culture, mobility and



metabolic activity can be used to identify the


K. pneumonia. Once the bacteria


installed and stained glass, straight rods 1 to 2 lm


length should be seen in the light microscope


(


). Once the form


, culture, there should be some smell of yeast,


and viscous / mucous


appearance (


). To ensure the absence of



moving structures such as flagella, motility test can be carried out >> << involving inoculation and incubation


semisolid agar deep tube


(Forbes


al ., 2002). Test results


need to show that bacteria remain on the site


vaccination. In addition, flagella stain can be performed,


, which should show no >> << to rolling stock. When Simmons citrate agar and incubated


sow, growth should be modified index


,


bromthymoll blue to green to blue, indicating


metabolic characteristics of citrate


(Forbes


al., 2002). Figure 4. Photomicrograph bacteria Klebsiella pneumonia


represent rod shape morphology. Other metabolic functions >>



K. pneumonia is its ability decarboxylize >> << amino acids, it can be checked by planting decarboxylase broth with



arginine, lysine and ornithine . After incubation


, the results should show the color change from


yellow-orange to purple,



indicates an alkaline pH (8. 0) in buy strattera connection with >> < <decarboxylation of amino acids. As mentioned earlier, K



pneumonia may esculine hydrolysis, which can be verified


seeding and incubation in the medium of this bacterium >>. << This Wednesday should be blackened,


, and the study by Woods lamp, there must be >> << fluorescence loss (Forbes


al.,


2002). This bacteria morphology,


cultural morphology, motility, and


metabolic functions allow it


identification and possible treatment. References: Forbes, BA, Castle, DF,


Weissfeld AS (2002). Bailey and Scotts


diagnostic microbiology (11th ed.). St. Louis, Missouri


: Mosby. Greenwood, D. Slack, RZB, Peutherer, JF (2002). Medical Microbiology: Manual


microbial infections: Pathogeneisis, immunity


laboratory diagnosis and control (16th ed.). Toronto, ON: Churchill Livingstone. .


homeopathic remedies for pneumonia

Scientists also found no convincing evidence...

For decades


recommended for patients with certain diseases of the heart to take antibiotics shortly before dental treatment. This was done with the belief that antibiotics will prevent infective endocarditis (IE), previously referred to as bacterial endocarditis. ANA last guidelines were published in scientific journal


application in April 2007 and is good news: AHA recommends that most of these patients require short-term antibiotics as a preventive measure before their treatment. The American Dental Association participated in the development of new principles and approved those areas relevant to dentistry. The guidelines were approved by the society of infectious diseases and children of America Infectious Diseases Society. Recommendations are based on the growing amount of scientific evidence showing the risks of preventive antibiotics outweigh the benefits for strattera 40mg most patients. The risks include adverse reactions to antibiotics that range from mild to severe and potentially, in very rare cases, death. Misuse of antibiotics can lead to drug-resistant bacteria. Scientists also found no convincing evidence that taking antibiotics before dental procedure prevents IE in patients at risk of developing heart disease. Their hearts are already often exposed to bacteria from the mouth that can get in their blood during basic daily activities such as brushes or dental floss. New guidelines on the basis of a comprehensive review of published studies that suggests IE, likely to occur as a result of these everyday activities than from dental procedures. New guidelines aimed at patients who would have the greatest risk of poor outcome if they developed heart disease. The new recommendations apply to many dental procedures, including cleaning teeth extraction. In patients with congenital heart disease can be difficult circumstances. They should check with their cardiologist if there is a general question as to the category that best meets their needs. . << >>

These findings should caution, however ...

3 bacteria shapes

Multilokusnye input sequence shows that many species of bacteria have a clonal structure, and that some clones were widespread. This is the main phylogeny was not detected by pulse field gel electrophoresis, a method suitable for strattera dosing short-term investigation of the outbreak. Some global multiresistant clones, it is easy to assume that it was distributed from a fire. These findings should caution, however, if there is a clear epidemiological should like PDAs carbapenemase-positive Klebsiella pneumonia ST258 with Greece on the north-west Europe. In other countries, created clones can repeatedly and independently of acquired resistance. Thus, global ST131 E. coli clone most CTX-M-15 extended spectrum b-lactamase (ESBL), but there is no ESBLs and a host of other ESBL types. We examine this interaction clone and resistance to E. coli, K. pneumonia, Acinetobacter baumannii-types, where three lines dominate the global - and Pseudomonas aeruginosa, which shows clonal diversity, but includes on "hard" serotype O12/Burst group 4 cluster, which proved to be an expert in the acquisition of resistance - from the PPE-1 VIM-1 b-lactamases - over 20 years. Thus, the "high risk clones" play an important role in the spread of resistance, the risk lies in their persistence - resulting from poorly understood features of survival - and flexible ability to collect and include resistance, and no permanent resistance batteries. In 2011 Federation of European Microbiological Societies. Posted by Blackwell Publishing Ltd. All rights reserved. .